What does it mean when an incidental exophytic, slightly hyperdense, indeterminate left renal lesion seen on a non‑contrast axial/posterior CT is described as 'if clinically indicated, this could be further evaluated with a renal protocol CT'?

Understanding "If Clinically Indicated, Further Evaluation with Renal Protocol CT"

This phrase means the radiologist cannot definitively characterize your exophytic, slightly hyperdense left renal lesion as benign on the non-contrast CT alone, and is recommending a dedicated multiphase contrast-enhanced CT (renal protocol) to determine whether this lesion is a benign cyst, a solid mass requiring treatment, or something in between.

What Makes Your Lesion "Indeterminate"

Your lesion is called indeterminate because:

• Non-contrast CT has limited ability to characterize renal masses — only homogeneous masses measuring <20 HU or >70 HU can be confidently called benign on non-contrast imaging 1
• "Slightly hyperdense" likely means the lesion measures between 20-70 HU, which falls into the indeterminate range that requires further evaluation 1
• Without contrast, the radiologist cannot assess for enhancement, which is the key feature distinguishing benign cysts from solid tumors that may be malignant 1

What "Renal Protocol CT" Means

A renal protocol CT is a specialized, multiphase contrast-enhanced CT that includes:

• Unenhanced (pre-contrast) phase to establish baseline attenuation 1
• Nephrographic/corticomedullary phase after IV contrast administration 1
• Delayed/excretory phase in some protocols 1

This protocol allows radiologists to detect enhancement (≥15-20 HU increase), which is the hallmark of solid masses including renal cell carcinoma (RCC), versus benign non-enhancing cysts 1.

Why This Matters for Your Health

The distinction between benign and malignant is critical because:

• Renal masses are increasingly detected incidentally, and many are small renal cell carcinomas with variable biological aggressiveness 1
• CT with contrast has 94.5% sensitivity for detecting RCC, though specificity is lower at 27.7% 1
• Recent evidence shows that homogeneous masses measuring 21-30 HU on portal venous phase CT are highly likely benign (0% malignancy rate in one large study), but your non-contrast study cannot provide this information 2
• Approximately 14-15% of patients undergoing non-contrast CT have incidental renal masses detected, and 13-15% of these are indeterminate requiring follow-up 3, 4

When to Actually Get the Renal Protocol CT

"If clinically indicated" means you should proceed with renal protocol CT if:

• You have no contraindication to IV iodinated contrast (no severe contrast allergy, adequate renal function) 1
• The lesion is truly new or of unknown chronicity 5
• You have reasonable life expectancy and would be a candidate for treatment if malignancy is found 1

You may NOT need immediate renal protocol CT if:

• The lesion is very small (<1 cm) and you have low risk factors for malignancy — some hyperechoic lesions ≤1 cm have 98.1% benign rate 6
• You have severe contrast allergy or renal insufficiency — in this case, MRI with gadolinium or contrast-enhanced ultrasound (CEUS) are alternatives 1
• You have limited life expectancy or significant comorbidities that would preclude treatment even if cancer were found 1

Alternative Imaging Options

If contrast-enhanced CT cannot be performed:

• MRI with IV gadolinium contrast is the best alternative, with higher specificity (68.1%) than CT (27.7%) for diagnosing RCC, while maintaining equivalent sensitivity 1
• Contrast-enhanced ultrasound (CEUS) has 95-100% sensitivity and 95% specificity for characterizing indeterminate renal masses and is particularly useful when CT/MRI contrast is contraindicated 1
• Non-contrast MRI can provide some diagnostic information for certain lesion types (simple cysts, hemorrhagic cysts) but is less accurate than contrast-enhanced imaging 1

Common Pitfalls to Avoid

• Do not assume "slightly hyperdense" means benign — this attenuation range (20-70 HU) includes both hemorrhagic/proteinaceous cysts AND solid tumors 1, 4
• Do not delay evaluation indefinitely — while many small renal masses have slow growth kinetics, some are aggressive malignancies 1
• Do not accept single-phase contrast CT as adequate — comprehensive renal mass evaluation requires both pre- and post-contrast imaging to accurately measure enhancement 1
• Recognize that "exophytic" location does not indicate benignity — both benign and malignant masses can be exophytic 1, 7

Bottom Line Recommendation

Proceed with renal protocol CT (unenhanced and contrast-enhanced) as the next step unless you have contraindications to iodinated contrast, in which case MRI with gadolinium or CEUS are appropriate alternatives 1. This imaging is essential to determine whether your lesion enhances (suggesting a solid mass requiring urologic evaluation) or represents a benign cyst that needs no further workup 1.